Syros Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Syros Pharmaceuticals, Inc. has filed 682 SEC EDGAR filings since 22 Aug 2012

SEC filing history

Showing 1-25 of 28 matching filings.

Per page
25
Current page
1
10-Q File 001-37813

SYRS-Q2-2022

Filing date
09 Aug 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
10-Q/A File 001-37813

10-Q/A

Filing date
24 Aug 2018
Reporting date
30 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 001-37813

10-Q/A

Filing date
24 Aug 2018
Reporting date
31 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .